SodaTide Ingredients: All Three, And What Each One Is

Three names and nothing else. That is the whole of the formula as the pack states it, and it is worth being precise about what has and has not been checked here. Every image the vendor supplies was opened: the two-bottle cutout, the three- and six-bottle shots, the ingredient graphic above, the everyday-use scene and all eight compliance roundels. None of them shows a panel, a serving box, a milligram or a colony count.

So the comparison table below is the only honest shape this page can take. In the left column, what the bottle says. In the right, the amount the published trials fed people. A reader can then do the arithmetic that the label declines to make possible, and this desk would rather hand over that arithmetic than pretend it does not matter.

Inulin is a fructan: a run of fructose units joined end to end and capped with a single glucose. Chicory builds it in the root across a growing season and lives on it through the winter, which is why the root rather than the leaf is what gets harvested. No enzyme in the human small intestine will touch the bond that joins one fructose to the next, so the whole chain reaches the colon as it was swallowed and is fermented there. The ISAPP consensus statement treats it as the archetypal prebiotic, and it has more human trials behind it than the rest of this category combined.

The dose where things start happening is known with unusual precision for a supplement ingredient. A double-blind crossover in thirty healthy adults gave 5 g and 8 g a day in a chocolate drink for two weeks each; both raised bifidobacteria against placebo, and a higher proportion of volunteers responded at 8 g. A 200-person dose-response study tested seven nondigestible carbohydrates at 2.5 to 10 g a day and found that long-chain inulin specifically was not bifidogenic in its screening phase, while short-chain fructo-oligosaccharides were — which is a reminder that 'inulin' covers a family of chain lengths that do not behave identically.

On the outcomes people actually buy it for, the picture is real but modest. A 2024 meta-analysis of 32 chicory inulin trials found reductions in body weight, BMI, fat mass and waist circumference, with minimal evidence that dose, duration or the type of fructan changed the size of the reduction. An earlier systematic review of fifteen adult trials found eleven showing no effect on daily energy intake at all, and two of three that measured body weight showing a reduction. Both of those statements are true at once, which is what a modest effect looks like.

Doses read from each paper's own abstract during this build.

Held against a capsule, those figures do the work this page exists to do. The lowest dose with a published effect on gut bacteria is five grams a day. A size 0 capsule holds four to five hundred milligrams of everything combined. Unless this bottle uses a capsule size that does not appear in any of its photographs, the inulin fraction is a fraction of a fraction of what the trials used.

The label says 'probiotic blend'. It does not say which bacteria, how many species, or how many live organisms are in a capsule at the end of shelf life. The seller's page describes three strains and names one of them in passing while answering a question about mechanism. The bottle names none.

For a fibre, a missing number is a problem of scale. For a probiotic it is a problem of identity, and the difference is worth stating carefully. The ISSN position stand on probiotics is explicit: health benefits are strain- and dose-dependent, the minimum effective dose depends on validation studies for that particular strain, and a product should carry the genus, species and strain of each organism plus the estimated count at the end of shelf life. A blend without those cannot be matched to a trial even in principle.

How much that matters is visible in the best-documented example in the field. Kadooka and colleagues gave 87 adults fermented milk containing Lactobacillus gasseri SBT2055 at 10⁸ cfu per gram, 200 g a day for twelve weeks, and measured a 4.6% fall in abdominal visceral fat area by CT. A follow-up in 210 people then asked whether lower concentrations worked, and found roughly 8% reductions at both 10⁷ and 10⁶ cfu per gram. The strain is named in the title of both papers, because the strain is the finding.

The storage line is the one row in this table the label does answer, and it is the row that suggests the organisms are meant to arrive alive.

The wider evidence for mixed probiotics in this use case is real and small. A meta-analysis of fifteen trials in 957 adults with overweight or obesity found reductions in body weight and fat percentage. An earlier meta-analysis found a small BMI effect. A 2025 meta-analysis looked specifically at visceral fat. A review restricted to Lactobacillus found the results split by species, with some reducing body fat and some doing nothing.

Two further things a buyer should know about probiotic labels generally. DNA-based authentication work exists precisely because label and contents have not always matched, and a laboratory audit of commercial products found poor correlation between label claims and measured identity, viability and counts. That is an argument for buying probiotics whose labels are specific, not an accusation about this one — but a label that names nothing cannot be checked against anything.

• Grams of inulin per capsule. One number, and every comparison on this page becomes possible for a reader in ten seconds.
• Grams of resistant starch per capsule, and the source form, since granule structure decides what ferments.
• Genus, species and strain for each organism in the blend, which is the unit probiotic evidence is keyed to.
• Colony-forming units at the end of shelf life, not at manufacture. The second number is the one a buyer receives.
• An other-ingredients line, so the capsule shell material and any excipient is on the pack rather than inferred from a vegetarian roundel.
• A best-before date beside the lot, which for a live-organism product is not a formality.

None of that is exotic. Every item on the list appears routinely on products in this category, and the six together would move this from a formula a reader has to take on trust to one they can check. It is printed here because a retailer who says nothing about disclosure is part of the disclosure problem.